ÃâÒßѧÊÔÌâ
hSgfp
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
C] <K s 1. Fas(CD95)/FasL
;CU<\ 2. common chain of cytokine receptor
d9zI
A6y 3 . TCR/CD3 complex
@#T*OH 4. negaive selection of thymocytes
|(gq:O 5. artificial active immune
05(lh<C 6. anti-idiotypic
_}X_^taTZS 7. IgSF
:*bmc /c 8. Integrin
Md \yXp 9. chemokine
8oSndfV 10. B7/CD28
XE_|H1&j ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
?_e2)+q8YG 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
Hno:"k? 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
{:&t;5qz^ 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
1 l'Wb2g>A 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
m*L*# ZBS
K/Q^8%Z 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
:)v4:&do µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
r;`6ML[5Vx Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
O:fv1 1. B7/CD28
@O}%sjC1 2. Th1 subset
6(4FC?Y7 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
](3e +JC 4. antibody affinity maturation
VnUWUIVJ 5. AP-1
?5e:w?&g@ 6. single chain variable fragment£¨ScFv£©
/,'D4s:Gg 7. NK cell receptor
'c 0]8Y4
8. Zinkernagel-Doherty phenomenon
c>~"Z-VtX 9. Ig fold
"?|sC{'C4j 10. CD40/CD40L
zhH-lMNj- ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
w66iLQ\@ 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
MtC \kTW 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
oL
Eqy 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
9L;fT5Tp7 Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
+]-~UsM 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
tz-, |n0 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
z{U2K' 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
8^CdE*a Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
_p/
_t76s £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
!6hUTjhW7z Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
~a KxwH 1.Co-stimulators (or co-stimulating molecules)
s^F6sXhyPi 2.NK-kB
iE$qq~% 3.Immunoglobulin superfamily
_NQMi4 V( 4.antigen-presenting cell (APC)
>[;+QVr; 5.death domain
hnag<= 6.CCR and CXCR
r9<OB`)3+ 7.Lectin (or mitogen)
'{+5+ J 8.Clusters of differentiation, CD)
Q@gmtAp 9.B7 family
$eUI.j(HU 10.Cytotoxic T lymphocyte, CTL)
"w.gP8` 11.IL-15 and IL-15 receptor (IL-15R)
]cvP ! 12.MHC restriction
nen( 13.Affinity-chromatography
rM/Ona2x 14.Cyctosprin A, CsA
{%W'Zx 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
g,Z8I;A^ ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
EaaLN<i@0 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
D4nYyj1O3
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
8D3|}z? 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
Lk
y<L96 Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
lezX-5Z ÃâÒßѧרҵ£º
IiW*'0H:/ 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
z2'3P{#s Ïû»¯ÄÚ¿Æ£º
%0 cFs' 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
A=8%2UwI ѪҺ²¡Ñ§×¨Òµ£º
f@Oi$9CZn 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
}7)iLfi Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
H,8HGL[l (רҵ»ù´¡: ÃâÒßѧ)
Egy#_ RT{ Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
CshYUr - 1. ADCC(antibody dependent cell-mediated cytotoxicity)
;1x(~pD*o 2. »·æß¾úËØ(cyclosporin)
.8[*`%K> 3. KIR(killer cell inhibitory receptor)
C8dC_9 4. HLDA(human leucocyte differentiation antigen)
cX~J6vNy5 5. Interleukin 18(IL-18)
j_]#Ew\q 6. ÕûºÏËØ(integrin)
3i\<#{ 7. Fas/FasL
,%Go.3i[ 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
lqaOLZH 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
vG X
L'k 10. Th1/Th2
vca]yK<u 11. »ùÒòÒßÃç(DNAÒßÃç)
NgI n\)
=0 12. chemokines and chemokine receptor
7bk=D~/nSg 13. ÃâÒßÄÍÊÜ
T( LlNq 14. ¹²´Ì¼¤·Ö×Ó
|FED< 15. ËÀÍö½á¹¹Óò(death domain)
7&O0 ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
]7|Zs]6 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
"+dByaY 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
1iLr
KA £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
^uCZO £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
.:wo
AR
W! £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
@1c[<3xJT £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
2=]Xe#5J=
3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
[\BLb8 Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
.X.,.vHx ÎÊ´ðÌâ(ÿÌâ25·Ö)
7gnrLc$]O 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
r)]8zK4;= 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
;0"p)O@s04 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
hI6Tp>b*~ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£